Differential Effects of Canonical Androgens and 11-Ketotestosterone on Reproductive Phenotypes and Folliculogenesis in Mouse Model of PCOS

Differential Effects of Canonical Androgens and 11-Ketotestosterone on Reproductive Phenotypes and Folliculogenesis in Mouse Model of PCOS

<b>Background</b>: Polycystic ovary syndrome (PCOS) is a common female endocrine disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. While canonical androgens like testosterone (T) and dihydrotestosterone (DHT) are well studied in PCOS pa...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi-Ru Tsai, Yen-Nung Liao, Cheng-Ju Tsai, Yu-Ang Lee, Shih-Min Hsia, Kuo-Chung Lan, Hong-Yo Kang
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Biomedicines
Subjects:	polycystic ovary syndrome hyperandrogenism androgen receptor 11-ketotestosterone
Online Access:	https://www.mdpi.com/2227-9059/13/5/1077
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Androgen-dependent diseases and their treatment
by: Marisa Cabeza
Published: (2024-12-01)

Hyperandrogenism-mediated YAP activation drives ovarian inflammation and pyroptosis in PCOS: implications for follicular dysfunction
by: Tianyue Xu, et al.
Published: (2025-07-01)

Altered bile acids profile is a risk factor for hyperandrogenism in lean women with PCOS: a case control study
by: Yuchen Zhu, et al.
Published: (2024-10-01)

The interplay between PCOS pathology and diet on gut microbiota in a mouse model
by: Valentina Rodriguez Paris, et al.
Published: (2022-12-01)

Proteomic analysis of human follicular fluid based on the 4D label free method to identify proteins that may affect oocyte quality in hyperandrogenic PCOS patients
by: Qianqian Yin, et al.
Published: (2025-05-01)

Spatial transcriptomics reveals Inhba/Smad2/E2f4 axis in Lrp2high thecal cell proliferation in androgen-induced PCOS mice
by: Man Luo, et al.
Published: (2025-08-01)

The effect of correction of serum level of vitamin D on hyperandrogenism in women with polycystic ovary syndrome and hypovitaminosis D
by: A. M. Maysara, et al.
Published: (2020-04-01)

Evidence for Increased Expression of SIRT3 Associated with Hyperandrogenism in Granulosa Cells of Non-Obese PCOS Patients
by: Shen Zhang, et al.
Published: (2022-11-01)

Clinical Pregnancy and Miscarriage Rates in relation to Vitamin D Supplementation among women with Hyper Androgenic PCOS: A prospective study
by: Sherif Sobhy Menshawy Khalifa, et al.
Published: (2025-01-01)

Ageing ovaries and endometrium in PCOS
by: Ambreen Usmani, et al.
Published: (2013-12-01)

Hyperandrogenism as a side effect of anticonvulsants
by: E. V. Tsallagova, et al.
Published: (2018-08-01)

Optimal Fasting Insulin Cutoff Value to Predict Clinical and/or Biochemical Hyperandrogenism in Korean Women with Polycystic Ovary Syndrome
by: Seula Lee, et al.
Published: (2023-11-01)

Follicular development and endometrial receptivity of different androgen phenotypes in women with polycystic ovary syndrome
by: Xinling Wen, et al.
Published: (2024-12-01)

Late bedtime was associated with increased androgen and reduced lean mass in women with polycystic ovary syndrome: a cross-sectional study
by: Yuqin Zhang, et al.
Published: (2025-07-01)

PCOS and Inositols &ndash; Advances and Lessons We are Learning. A Narrative Review
by: Lentini G, et al.
Published: (2025-05-01)

The PCOS Phenotypes in Unselected Populations (P-PUP) study: participant clinical features and data harmonization on analysis of individual participant data
by: Asmamaw Demis Bizuneh, et al.
Published: (2025-07-01)

Does Baseline Serum Androgen Levels Have an Impact on Ovulation Induction Cycle Outcomes by Using Clomifene Citrate among Infertile Women with Polycystic Ovary Syndrome? A Retrospective Cohort Study
by: Serkan Kahyaoglu, et al.
Published: (2023-08-01)

The association between phenotypes of polycystic ovary syndrome and metabolic dysfunction-associated fatty liver disease
by: So-hyeon Hong, et al.
Published: (2025-08-01)

Impact of polycystic ovary syndrome on the atherogenic plasma index: A retrospective analysis
by: Huseyin Demirci, et al.
Published: (2025-07-01)

Effects of non-pharmacological interventions on biochemical hyperandrogenism in women with polycystic ovary syndrome: a systematic review and network meta-analysis
by: Qi Jin, et al.
Published: (2025-01-01)

The role of microbiota and toll-like receptors in polycystic ovary syndrome: regulatory mechanisms of androgen metabolism
by: Xueming Huang, et al.
Published: (2025-06-01)

Protective effect of Yunkang oral liquid via regulating androgen receptor in polycystic ovary syndrome rats
by: Xiang Zheng, et al.
Published: (2024-12-01)

SCLEROCYSTIC OVARIES: CURRENT APPROACHES TO THE PROBLEM
by: A. G. Solopova, et al.
Published: (2017-08-01)

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study
by: Manman Pan, et al.
Published: (2023-08-01)

Lipoprotein Biology During Induced Oogenesis in the Shortfinned Eel, <i>Anguilla australis</i>—Vascular Transport
by: Erin L. Damsteegt, et al.
Published: (2024-12-01)

Multiomics and Systematic Analyses Reveal the Roles of Hemoglobin and the HIF‐1 Pathway in Polycystic Ovary Syndrome
by: Guiquan Wang, et al.
Published: (2025-04-01)

Impact of Polycystic Ovary Syndrome Hyperandrogenic Phenotypes A and Non-Hyperandrogenic D on Pregnancy Outcomes After in vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI)
by: Khamaiseh K, et al.
Published: (2025-03-01)

Assessment of metabolic risk among the Rotterdam's polycystic ovary syndrome phenotypes in Bangalore
by: Chandrika Anand, et al.
Published: (2024-10-01)

Polycystic Ovary Syndrome - treatment update
by: Marta Szymura, et al.
Published: (2025-07-01)

a1-antitrypsin, a new biomarker of polycystic ovary syndrome by changing its expression and rhythm
by: Na Li, et al.
Published: (2025-05-01)

Hormonal contraception in women with polycystic ovary syndrome: Contraceptive and non-contraceptive effects. A clinical lecture
by: Olga A. Pustotina
Published: (2024-12-01)

Treatment of adolescent girls with polycystic ovary syndrome and insulin resistance
by: E. M. Bogatyreva, et al.
Published: (2018-07-01)

Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome
by: Khulood Hussein, et al.
Published: (2023-06-01)

Exploration of the molecular mechanism of melatonin against polycystic ovary syndrome based on a network pharmacology approach and experimental validation
by: Ran Cheng, et al.
Published: (2025-08-01)

Chemerin and Polycystic Ovary Syndrome: A Comprehensive Review of Its Role as a Biomarker and Therapeutic Target
by: Stefano Palomba, et al.
Published: (2024-12-01)

Evaluation of Ovarian Stromal Microvascularity and Clinical-Hormonal Associations in Reproductive-Aged Women with Polycystic Ovary Morphology
by: Hakan Baş, et al.
Published: (2025-05-01)

Effects of cryptotanshinone in treatment of polycystic ovary syndrome in rats: a systematic review and meta-analysis
by: Pingping Su, et al.
Published: (2025-05-01)

The roles of MAPK signaling pathway in ovarian folliculogenesis
by: Hong Zhao, et al.
Published: (2025-07-01)

Clinical utility of FAI and SHBG in differentiating PCOS from anovulatory cycles in adolescent girls
by: Emre Özer, et al.
Published: (2025-08-01)

Wilson disease combined with polycystic ovary syndrome–clinical features, treatment, and outcome in Chinese patients
by: Lin Chen, et al.
Published: (2025-03-01)